Comparison of Point of Care to Lab INR in Dialysis Patients on Warfarin
To determine whether point of care (POC) International Normalized Ratio (INR) test results correlate with plasma INR measures in hemodialysis patients.
Anticoagulation in Dialysis Patients
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Correlation of Point of Care INR to Laboratory INR in Hemodialysis Patients Taking Warfarin|
- To determine whether Point of Care INR testing would be suitable in the management of dialysis patients on chronic warfarin therapy [ Time Frame: Not an intervention study, but observational in this cohort ] [ Designated as safety issue: No ]
- Determine whether Point of Care INR devices maintain test accuracy in dialysis patients who are temporarily anemic (HCT <32%) according to their CBC [ Time Frame: Not an intervention study, but observational in the cohort (statistics completed 1.5 yrs) ] [ Designated as safety issue: No ]
|Study Start Date:||June 2005|
|Study Completion Date:||December 2005|
|Primary Completion Date:||December 2005 (Final data collection date for primary outcome measure)|
37 dialysis patients
37 chronic hemodialysis patients on warfarin requiring Laboratory INR monitoring for anticoagulation management.
37 chronic hemodialysis patients being anticoagulated with warfarin require INR monitoring routinely.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00660946
|Principal Investigator:||Robert W. Hoel, Pharm D||Mayo Clinic Rochester, Mn USA|